Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Mar 8:14:1110525.
doi: 10.3389/fpsyt.2023.1110525. eCollection 2023.

Striatal increase of dopamine receptor 2 density in idiopathic and syndromic mouse models of autism spectrum disorder

Affiliations

Striatal increase of dopamine receptor 2 density in idiopathic and syndromic mouse models of autism spectrum disorder

Stuti Chhabra et al. Front Psychiatry. .

Abstract

Autism spectrum disorder (ASD) comprises a wide range of neurodevelopmental phenotypes united by impaired social interaction and repetitive behavior. Environmental and genetic factors are associated with the pathogenesis of ASD, while other cases are classified as idiopathic. The dopaminergic system has a profound impact in the modulation of motor and reward-motivated behaviors, and defects in dopaminergic circuits are implicated in ASD. In our study, we compare three well-established mouse models of ASD, one idiopathic, the BTBR strain, and two syndromic, Fmr1 and Shank3 mutants. In these models, and in humans with ASD, alterations in dopaminergic metabolism and neurotransmission were highlighted. Still, accurate knowledge about the distribution of dopamine receptor densities in the basal ganglia is lacking. Using receptor autoradiography, we describe the neuroanatomical distribution of D1 and D2 receptors in dorsal and ventral striatum at late infancy and adulthood in the above-mentioned models. We show that D1 receptor binding density is different among the models irrespective of the region. A significant convergence in increased D2 receptor binding density in the ventral striatum at adulthood becomes apparent in BTBR and Shank3 lines, and a similar trend was observed in the Fmr1 line. Altogether, our results confirm the involvement of the dopaminergic system, showing defined alterations in dopamine receptor binding density in three well-established ASD lines, which may provide a plausible explanation to some of the prevalent traits of ASD. Moreover, our study provides a neuroanatomical framework to explain the utilization of D2-acting drugs such as Risperidone and Aripiprazole in ASD.

Keywords: ASD; autism (ASD); dopamine receptor (d1r and d2r); dorsal striatum; receptor autoradiography; ventral striatum.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Exemplary section from a BTBR 12-week-old mouse showing DS and VS in an HE stained section (A,D), autoradiographic image of binding to D1 (B) and D2 receptors (E), and the corresponding color-coded picture of the same autoradiogram [(C,F) respectively].
Figure 2
Figure 2
Bar charts representing mean and SEM of the receptor density for D1 receptors. DS: C57BL6/J (n = 8), BTBR (n = 8) and VS: C57BL6/J (n = 8), BTBR (n = 8) at 4 weeks of age (A); DS: C57BL6/J (n = 10), BTBR (n = 11) and VS: C57BL6/J (n = 10), BTBR (n = 11) at 12 weeks of age (B); DS: Fmr1 WT (n = 9), Fmr1 KO mice (n = 8) and VS: Fmr1 WT (n = 9) and Fmr1 KO mice (n = 7) at 4 weeks of age (C); DS: Fmr1 WT (n = 7), Fmr1 KO mice (n = 8) and VS: Fmr1 WT (n = 7) and Fmr1 KO mice (n = 8) at 12 weeks of age (D); DS: Shank3b WT (n = 5), Shank3b KO mice (n = 6) and VS: Shank3b WT (n = 5), Shank3b KO mice (n = 6) at 4 weeks of age (E); DS: Shank3b WT (n = 14), Shank3b KO mice (n = 12) and VS: Shank3b WT (n = 14) and Shank3b KO mice (n = 12) at 12 weeks of age (F). Significant differences are indicated with an asterisk (*p < 0.05). Changes are represented as percentage of the mean of C57BL6/J, Fmr1 WT, Shank3b WT mice, respectively.
Figure 3
Figure 3
Bar charts representing mean and SEM of the receptor density for D2 receptors. DS: C57BL6/J (n = 9), BTBR (n = 8) and VS: C57BL6/J (n = 9), BTBR (n = 6) at 4 weeks of age (A); DS: C57BL6/J (n = 10), BTBR (n = 9) and VS: C57BL6/J (n = 10), BTBR (n = 7) at 12 weeks of age (B); DS: Fmr1 WT (n = 8), Fmr1 KO mice (n = 8) and VS: Fmr1 WT (n = 8) and Fmr1 KO mice (n = 8) at 4 weeks of age (C); DS: Fmr1 WT (n = 5), Fmr1 KO mice (n = 8) and VS: Fmr1 WT (n = 5) and Fmr1 KO mice (n = 8) at 12 weeks of age (D); DS: Shank3b WT (n = 6), Shank3b KO mice (n = 6) and VS: Shank3b WT (n = 6), Shank3b KO mice (n = 6) at 4 weeks of age (E); DS: Shank3b WT (n = 12), Shank3b KO mice (n = 12) and VS: Shank3b WT (n = 12) and Shank3b KO mice (n = 11) at 12 weeks of age (F). Significant differences are indicated with an asterisk (*p < 0.05). Changes are represented as percentage of the mean of C57BL6/J, Fmr1 WT, Shank3b WT mice, respectively.

References

    1. Lord C, Brugha TS, Charman T, Cusack J, Dumas G, Frazier T, et al. . Autism spectrum disorder. Nat Rev Dis Primers. (2020) 6:5. doi: 10.1038/s41572-019-0138-4, PMID: - DOI - PMC - PubMed
    1. Zeidan J, Fombonne E, Scorah J, Ibrahim A, Durkin MS, Saxena S, et al. . Global prevalence of autism: a systematic review update. Autism Res. (2022) 15:778–90. doi: 10.1002/aur.2696, PMID: - DOI - PMC - PubMed
    1. Won H, Mah W, Kim E. Autism spectrum disorder causes, mechanisms, and treatments: focus on neuronal synapses. Front Mol Neurosci. (2013) 6:19–9. doi: 10.3389/fnmol.2013.00019, PMID: - DOI - PMC - PubMed
    1. Masi A, DeMayo MM, Glozier N, Guastella AJ. An overview of autism Spectrum disorder, heterogeneity and treatment options. Neurosci Bull. (2017) 33:183–93. doi: 10.1007/s12264-017-0100-y, PMID: - DOI - PMC - PubMed
    1. Wise RA. Dopamine, learning and motivation. Nat Rev Neurosci. (2004) 5:483–94. doi: 10.1038/nrn1406 - DOI - PubMed

LinkOut - more resources